Boron Neutron Capture Therapy Using CICS-1 and SPM-011 for Malignant Melanoma and Angiosarcoma
Conditions: Malignant Melanoma; Angiosarcoma Intervention: Other: CICS-1 (investigational device),SPM-011(investigational drug) Sponsors: Cancer Intelligence Care Systems, Inc.; Stella Pharma Corporation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials